Clinical trial register · Turkey

Clinical Trials in Antalya, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5443 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:18 UTC

5443

Studies in scope

all four open statuses

2494

Recruiting now

open to new participants

547

Lead sponsors

across recruiting studies

Top sites

Istanbul 2009 Ankara 1431 Izmir 558 Adana 379 Antalya 267

Trials with a site in Antalya

Status

Study

Lead sponsor

Phase

Enrol

Sites in Turkey

Start

Not yet open

Comparison of Serratus Posterior Superior Intercostal Plane Block and Rhomboid Intercostal Block in Patients Undergoing Breast Cancer Surgery

NCT07536867Breast Cancer, Lymph Node Dissection, Postoperative Pain, Mastectomy

Antalya City Hospital

Not applicable

Antalya

2026-12-30

Not yet open

Intertransverse Process Block Versus Subcostal Transversus Abdominis Plane Block After Laparoscopic Sleeve Gastrectomy

NCT07591129Intertransverse Process Block, Subcostal Transverse Abdominis Plane Block, Sleeve Gastrectomy, Postoperative Pain

Antalya City Hospital

Not applicable

Antalya

2026-12-30

Not yet open

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

NCT07900633Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2

DrugEloralintide

Eli Lilly and Company

Phase 3

3,000

Adana, Ankara, Antalya, Diyarbakır, Eskişehir, Istanbul, Kayseri, Kocaeli

2026-12

Not yet open

Comparison of Serratus Posterior Superior Intercostal Plane Block and Deep Serratus Anterior Plane Block After Video-Assisted Thoracoscopic Surgery

NCT07553195Postoperative Pain, Video Assisted Thoracic Surgery (VATS), Serratus Posterior Superior Intercostal Plane Block, Deep Serratus Anterior Plane Block

Antalya City Hospital

Not applicable

Antalya

2026-11-30

Not yet open

SPSIP vs ESP Block for Analgesia After Rib Fracture Surgery

NCT07553208Rib Fracture, Postoperative Pain, Thoracic Trauma

Antalya City Hospital

Not applicable

Antalya

2026-11-15

Not yet open

Effect of Intracanal Cryotherapy on Pain, Anxiety, and Salivary Irisin After Root Canal Treatment

NCT07889050Postoperative Pain After Endodontic Treatment, Dental Anxiety, Root Canal Treatment

Alanya Alaaddin Keykubat University

Not applicable

130

Antalya

2026-11-01

Recruiting

Effects of Tele-rehabilitation-Guided Qigong on Children and Adolescents With Asthma

NCT07883967Asthma Childhood

Antalya Health Sciences University

Not applicable

Antalya

2026-10-15

Not yet open

Qigong Intervention for Fibromyalgia

NCT07830186Fibromyalgia

Saglik Bilimleri Universitesi

Not applicable

Antalya

2026-10-15

Not yet open

Effects of Action Observation and Motor Imagery on PNF Skill Learning in Physiotherapy Students

NCT07873515Motor Skill Learning

Antalya Bilim University

Not applicable

Antalya

2026-10-12

Recruiting

Clinical Management and Outcomes After Lung Scintigraphy for Suspected Pulmonary Embolism in the Emergency Department

NCT07905781Pulmonary Embolism (Diagnosis)

Antalya Health Sciences University

Observational

100

Antalya

2026-10-10

Recruiting

Comparison of Kinesio Taping Techniques in Ulnar Nerve Entrapment

NCT07863830Ulnar Nerve Entrapment, Cubital Tunnel Syndrome, Ulnar Neuropathy at Elbow

Antalya Training and Research Hospital

Not applicable

Antalya

2026-10-09

Not yet open

Videolaryngoscopic Difficult ıntubation and Glottic View Score: A Multicentre Prospective Study

NCT07355608Airway Management

Diskapi Teaching and Research Hospital

Observational

4,977

Ankara, Antalya

2026-10-01

Not yet open

Combined Metabolic Activator Supplementation in Subjects Diagnosed With Gout

NCT07889284Gout Disease

DrugCombined metabolic activators

ScandiBio Therapeutics AB

Phase 3

336

Ankara, Antalya, Erzurum, Eskişehir, Istanbul

2026-10

Recruiting

A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

NCT07665450Multiple Myeloma

DrugsRamantamig·Bortezomib·Daratumumab·Lenalidomide

Janssen Research & Development, LLC

Phase 3

1,000

Ankara, Antalya, Istanbul, Izmir, Samsun

2026-09-09

Recruiting

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

NCT07680790Non-Small Cell Lung Cancer

DrugsIza-bren·Osimertinib·Pemetrexed·Cisplatin

Bristol-Myers Squibb

Phase 3

850

Sur, Pendik, Adana, Ankara, Antalya, Istanbul, Izmir

2026-09-08

Recruiting

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

NCT07624305Renal Insufficiency, Chronic

DrugDapagliflozin

AstraZeneca

Phase 3

2,800

Adapazarı, Ankara, Antalya, Dinar, İzmit, Kahramanmaraş, Kayseri, Kazımkarabekir

2026-09-01

Not yet open

Effect of Adding a Biceps Femoris Short Head Block to Adductor Canal Block for Analgesia After Total Knee Arthroplasty

NCT07803887Knee Osteoarthritis (OA), Postoperative Pain

Antalya Training and Research Hospital

Not applicable

122

Antalya

2026-09-01

Not yet open

Preoperative Breathing Exercise Training and Postoperative Delirium After Robotic Radical Prostatectomy

NCT07766603Postoperative Delirium (POD), Prostate Cancer

ALİ DEMİRTAŞ

Not applicable

Antalya

2026-09

Not yet open

Analgesic Efficacy of Intertransverse Process Block Versus Erector Spinae Plane Block

NCT07583602Robotic Colorectal Surgery, Erector Spine Plane Block, Intertransverse Process Block, Postoperative Pain

Antalya City Hospital

Not applicable

Antalya

2026-08-30

Recruiting

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

NCT07776509Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2

DrugLenbelintide

AstraZeneca

Phase 3

500

Ankara, Antalya, Center, Istanbul

2026-08-24

Recruiting

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)

DrugElecoglipron

AstraZeneca

Phase 3

6,950

Adana, Ankara, Antalya, Center, Istanbul, Izmir, Kahramanmaraş, Kütahya

2026-08-24

Recruiting

Effect of Different Apical Motion Algorithms on Postoperative Pain After Root Canal Treatment

NCT07714733Apical Periodontitis, Postoperative Pain After Endodontic Treatment

Alanya Alaaddin Keykubat University

Not applicable

120

Antalya

2026-08-20

Not yet open

Clinical Characteristics and In-Hospital Outcomes of Critically Ill Patients Receiving Hemodialysis or Continuous Venovenous Hemodiafiltration in the Emergency Department

NCT07765030Acute Kidney Injury, Kidney Failure, Acute, Kidney Failure

Antalya Health Sciences University

Observational

150

Antalya

2026-08-10

Recruiting

Effects of Stellate Ganglion Block on Delirium and Circadian Rhythm in Geriatric Intensive Care Patients

NCT07558642Stellate Ganglion Block

Antalya Training and Research Hospital

Not applicable

130

Antalya

2026-08-06

Not yet open

Elastic Band Exercises With Blood Flow Restriction Technique in Tennis Players

NCT07676071Elastic Band Exercises, Blood Flow Restrictive Exercises, Tennis

Akdeniz University

Not applicable

Antalya

2026-08-01

Not yet open

Three-Dimensional Scoliosis Exercises and Diaphragmatic Manual Techniques in Adolescents With Idiopathic Scoliosis

NCT07683533Adolescent Idiopathic Scoliosis, Diaphragmatic Manual Techniques, Schroth Exercises

Akdeniz University

Not applicable

Antalya

2026-08-01

Active, closed

Virtual Reality Exergaming During Work Breaks in Office Employees

NCT07749196Exergaming, Virtual Reality Physical Activity, Workplace Exercise

Akdeniz University

Not applicable

Antalya

2026-07-29

Recruiting

Triage Performance and Physiological Predictors of Serious Illness in Febrile Children in the Pediatric Emergency Department

NCT07739004Fever, Triage, Pediatric Emergency Medicine, Serious Bacterial Infection

TC Erciyes University

Observational

3,000

Kayseri, Adana, Antalya, Eskişehir, Istanbul, Izmir, Manisa, Tokat Province

2026-07-28

Not yet open

Predictive Performance of NEWS-2 and NEWS-Calcium Scores for In-Hospital Mortality in Older Patients With Acute Pancreatitis

NCT07640971Acute Pancreatitis (AP), News-2, Prediction of In-Hospital Mortality in Older Patients With Acute Pancreatitis

Antalya Health Sciences University

Observational

350

Antalya

2026-07-15

Recruiting

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

NCT07662135Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease

DrugElecoglipron

AstraZeneca

Phase 3

900

Adana, Ankara, Antalya, Bakırköy, Gaziantep, Kayseri, Yüreğir

2026-07-06

Recruiting

THE EFFECT OF 'RHYTHMİC SKİN TAPPİNG' AND INTERNAL VİBRATİON APPLİED PROXİMAL TO THE PROCEDURE SİTE ON PAİN AND FEAR PERCEPTİON DURİNG PEDİATRİC PERİPHERAL VENİPUNCTURE

NCT07650591Procedural Pain, Acute Pain, Needle-Related Pain and Distress, Fear

Akdeniz University

Not applicable

126

Antalya

2026-07-01

Recruiting

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

NCT07667803Weight Management

DrugElecoglipron

AstraZeneca

Phase 3

4,500

Adana, Adapazarı, Ankara, Antalya, Istanbul

2026-06-29

Not yet open

Bispectral Index in Patients Undergoing Vertebral Surgery Using Artificial Intelligence Programs: A Methodological Study

NCT07650604Artifical Intelligence, Bispectral Index, Spine

Antalya Health Sciences University

Observational

Antalya

2026-06-10

Not yet open

Cerebral Near-infrared Spectroscopy in Patients Undergoing Open Cardiovascular Surgery Using Artificial Intelligence Programs: A Methodological Study

NCT07654244Clinical Suitability of Artificial Intelligence Programs, Near Infrared Spectroscopy, Cardiac Surgery

Antalya Health Sciences University

Observational

Antalya

2026-06-10

Recruiting

Fascial Plane Blocks In Cardiac Surgery

NCT07622823Cardiovascular Surgery, Regional Anaesthesia, Postoperative Analgesia

Antalya Health Sciences University

Observational

Antalya

2026-06-01

Not yet open

Pulmonary Artery Pressure in Predicting Pulmonary Embolism in Patients Presenting To The Emergency Department With Dyspnea

NCT07641400Emergency Department Patients, Pulmonary Hypertension, Pulmonary Embolism

Antalya Health Sciences University

Observational

Antalya

2026-06-01

Not yet open

Application of a Fasting-mimicking Diet in Obese Patients With Periodontitis Stage III-IV

NCT07549633Periodontitis (Stage 3), Periodontitis Stage IV

Akdeniz University

Not applicable

Antalya

2026-06-01

Active, closed

Generative AI-Supported Personalized Education Compared With Printed Material for Adults With Hypertension

NCT07776834Hypertansion

Akdeniz University

Not applicable

Antalya

2026-06-01

Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT07518186Multiple Myeloma

DrugsRamantamig·Teclistamab

Janssen Research & Development, LLC

Phase 3

700

Ankara, Antalya, Istanbul, Izmir, Mersin, Samsun

2026-05-31

Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT07577856Colitis, Ulcerative

DrugsJNJ-78934804·Tremfya·Guselkumab

Janssen Research & Development, LLC

Phase 3

644

?zmir, Antalya, Gaziantep, Istanbul, Kocaeli, Mersin, Turanköy

2026-05-23

Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

NCT07577843Crohn Disease

DrugsJNJ-78934804·Tremfya·Guselkumab

Janssen Research & Development, LLC

Phase 3

460

?zmir, Antalya, Istanbul, Kocaeli, Mersin, Turanköy

2026-05-22

Not yet open

Systemic Inflammatory Markers In Vocal Cord Lesions

NCT07626125Laryngeal Lesions, Systemic Inflammatory Process

Antalya Health Sciences University

Observational

250

Antalya

2026-05-22

Recruiting

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

NCT07413939HER2-positive Breast Cancer

DrugsZN-A-1041·Tucatinib·Trastuzumab·Capecitabine

Hoffmann-La Roche

Phase 2/3

650

Altındağ, Ankara, Antalya, Bakirkoy / Istanbul, Bornova, Izmir, Erdine, Istanbul, Izmir

2026-05-21

Recruiting

Effect of Postoperative Holistic Nursing Care on Children's Satisfaction and Nursing Image Perception

NCT07455266Pediatric Surgical Patients, Postoperative Care

Akdeniz University

Not applicable

Antalya

2026-05-18

Not yet open

Telerehabilitation-Based Dance Therapy in Pediatric Cancer

NCT07596745Pediatric Cancer, Rehabilitation

Akdeniz University

Not applicable

Antalya

2026-05-16

Recruiting

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

NCT07567001Obesity, Heart Failure

DrugNNC0487-0111

Novo Nordisk A/S

Phase 3

5,610

Adana, Adapazarı/Sakarya, Afyonkarahisar, Altınordu/Ordu, Ankara, Antalya, Bayraklı/İzmir, Bursa

2026-05-11

Recruiting

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

NCT07509151Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV

DrugSurovatamig

AstraZeneca

Phase 3

420

Adapazarı, Antalya, Istanbul, Kocaeli, Mezitli

2026-05-05

Recruiting

The Impact of Video-assisted Thoracic Surgery and Regional Anaesthesia on Postoperative Opioid Consumption and Pain Scores

NCT07578545Thoracic Surgery, Videoassisted Thoracoscopic Surgery,One-lung Ventilation, Regional Anaesthesia, Postoperative Analgesia

Antalya Training and Research Hospital

Observational

Antalya

2026-05-04

Recruiting

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

DrugMK-1045

Merck Sharp & Dohme LLC

Phase 1/2

280

Ankara, Antalya, Istanbul, Samsun

2026-05-03

Recruiting

Bispectral Index and First-Pass Intubation

NCT07690254Emergency Airway Management

Akdeniz University Hospital

Observational

150

Antalya

2026-05-01

Recruiting

Axillary Web Syndrome After Breast Cancer Surgery: Incidence, Risk Factors, and Functional Outcomes

NCT07780240Axillary Web Syndrome, Breast Cancer, Breast Cancer Lymphedema, Postoperative Complications

Antalya City Hospital

Observational

250

Istanbul, Antalya

2026-05-01

Recruiting

Assessment of Hemodynamic Responses at Adequate Depth of Anesthesia Using Bispectral Index During Rapid Sequence Intubation in the Emergency Department

NCT07722897Critical Illness

Akdeniz University Hospital

Observational

200

Antalya

2026-05-01

Recruiting

The Effects of Regional Anaesthesia Techniques on Hemidiaphragm Paralysis, Postoperative Recovery Quality, Opioid Consumption, and Pain Scores

NCT07553611Regional Anaesthesia, Arthroscopic Shoulder Surgery, Hemidiaphragmatic Paralysis, Recovery Quality

Antalya Training and Research Hospital

Observational

Antalya

2026-04-21

Active, closed

Evaluation of MTHFR and DNMT3B Gene Polymorphisms Along With Periodontal Clinical Parameters in Healthy Individuals and Individuals With Type 2 Diabetes and Periodontitis

NCT07905209Periodontitis, Type 2 Diabetes Mellitus (DM)

Akdeniz University

Observational

200

Antalya

2026-04-02

Recruiting

Serum Fetuin-A and COMP Levels in Knee Osteoarthritis

NCT07706569Knee Osteoarthritis, Osteoarthritis, Knee

Antalya Training and Research Hospital

Observational

180

Antalya

2026-04-01

Not yet open

Comparison of Frailty, Physical Fitness Parameters, and Irisin Levels Between Patients With Multiple Sclerosis and Healthy Volunteers

NCT07521982MULTIPL SCLEROSİS

Baskent University

Observational

782

Antalya

2026-04-01

Recruiting

Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction

NCT07124741Septic Shock, VExUS

Antalya Training and Research Hospital

Observational

100

Antalya

2026-03-30

Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe

DrugZotemtegrast

Eli Lilly and Company

Phase 2

1,431

Adana, Ankara, Antalya, Bornova, Hatay, Istanbul, İzmit, Mersin

2026-03-26

Not yet open

Technology-based Hand Rehabilitation in Older People

NCT07507279Older Adults (65 Years and Older)

Akdeniz University

Not applicable

Antalya

2026-03-25

Recruiting

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

NCT07351058Obesity or Overweight, Type 2 Diabetes Mellitus

Hoffmann-La Roche

Phase 3

1,600

Istanbul, Adana, Ankara, Antalya, Izmir, Sariçam

2026-03-23

Recruiting

Comparison of Suction and Conventional Ureteral Access Sheaths in Kidney Stone Surgery

NCT07866209Kidney Calculi, Nephrolithiasis

Antalya Health Sciences University

Observational

160

Antalya

2026-03-18

Recruiting

The Impact of a Nursing Care Program Based on Human Caring Theory on Adolescents With Self-harm

NCT07368556Self Harm

Akdeniz University

Not applicable

Antalya

2026-03-18

Not yet open

Transcranial Doppler and NIRS Monitoring of Cerebral Hemodynamics in Pediatric Laparoscopic Surgery

NCT07482514Cerebral Perfusion Pressure, Trendelenburg, Pediatric

Hanife Kabukcu

Observational

Antalya

2026-03-16

Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

NCT07361497Non-small Cell Lung Cancer (NSCLC)

DrugsPumitamig·Durvalumab

Bristol-Myers Squibb

Phase 3

850

Adana, Antalya, Çankaya, Istanbul

2026-03-16

Recruiting

Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study)

NCT07459426Hepatitis B, Chronic

Yaşar Bayındır, MD

Observational

700

Adana, Ankara, Antalya, Diyarbakır, Gaziantep, Izmir, Kocaeli, Malatya

2026-03-15

Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

NCT07361510Non-Small Cell Lung Cancer (NSCLC)

DrugsPumitamig·Pembrolizumab

Bristol-Myers Squibb

Phase 3

750

Adana, Ankara, Antalya, Cordaleo, Çankaya, Istanbul, Izmir

2026-03-12

Recruiting

Effects of Graded Motor Imagery in Individuals With Foot/Ankle Osteoarthritis

NCT07417436Ankle Osteoarthritis, Foot Osteoarthritis

Alanya Alaaddin Keykubat University

Not applicable

Antalya

2026-03-10

Recruiting

HBV Reactivation in Immunocompromised Patients (REANT STUDY)

NCT07529171HBV

Yaşar Bayındır, MD

Observational

490

Adana, Ankara, Antalya, Diyarbakır, Düzce, Gaziantep, Istanbul, Izmir

2026-03-09

Active, closed

Investigation of the Association of Multimodal Neuroimaging and Peripheral Biomarkers With Executive Functions and Emotional Regulation in Adolescents With Attention-Deficit/Hyperactivity Disorder

NCT07800117Attention-Deficit/Hyperactivity Disorder (ADHD)

Akdeniz University

Observational

Antalya

2026-03-01

Active, closed

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

NCT07266441Multiple Myeloma

DrugRamantamig

Janssen Research & Development, LLC

Phase 2

168

Ankara, Antalya, Istanbul, Sakarya

2026-02-08

Recruiting

GDF-15 and Early Outcomes After LVAD Implantation

NCT07497308Advanced Heart Failure, Left Ventricular Assist Device Implantation

Akdeniz University

Observational

Antalya

2026-02-04

Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

NCT07431281Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Cancer

DrugsSonesitatug Vedotin·Zolbetuximab·Rilvegostomig·Leucovorin

AstraZeneca

Phase 3

2,130

Ankara, Antalya, Istanbul, Medreseboğazı, Şahinbey

2026-02-03

Recruiting

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

NCT07359846Severe Asthma

DrugGB-0895

Generate Biomedicines

Phase 3

786

Ankara, Antalya, Denizli, Samsun, Trabzon, Bursa

2026-01-20

Recruiting

A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies

NCT07308132Lymphoma, Non-Hodgkin

DrugsJNJ-87801493·Loncastuximab Tesirine·Polatuzumab Vedotin·Vincristine

Janssen Research & Development, LLC

Phase 1

340

Ankara, Antalya, Istanbul

2026-01-20

Recruiting

Effectiveness of a Visual Feedback Exercise Program Following Lumbar Surgery

NCT07382830Lumbar Microdiscectomy, Postoperative Rehabilitation, Randomized Controlled Trial

Suleyman Demirel University

Not applicable

Antalya

2026-01-16

Recruiting

Comparison of Endoscopic and Open Surgery for Gynecomastia

NCT07653152Gynecomastia

Antalya City Hospital

Observational

100

Antalya, Istanbul

2026-01-08

Active, closed

Comparison of the Effectiveness of Nerve Hydrodissection With Saline Injection of 5% Dextrose in Carpal Tunnel Syndrome.

NCT07524933Conditions

Antalya Training and Research Hospital

Not applicable

Antalya

2026-01-08

Recruiting

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

NCT07063745Metastatic Non-small Cell Lung Cancer With MTAP Deletion

DrugsNavlimetostat·Nab-paclitaxel·Pemetrexed·Paclitaxel

Bristol-Myers Squibb

Phase 2/3

590

Izmir, Karsiyaka, Adana, Ankara, Antalya, Bursa, Edirne, Istanbul

2026-01-02

Recruiting

Does Chronic Pain Change Over Time in Children With Duchenne Muscular Dystrophy?

NCT07892196Duchenne Muscular Dystrophy (DMD), Chronic Pain, Neuromuscular Diseases (NMD)

Antalya Training and Research Hospital

Observational

Antalya

2026-01-02

Not yet open

Evaluation of Cerebral Perfusion in Supine and Steep Trendelenburg Positions During Robotic Prostatectomy

NCT07317258Cerebral Perfusion Pressure, Trendelenburg

Hanife Kabukcu

Observational

Antalya

2026-01-01

Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

NCT07185997Non-Small-Cell Lung Cancer, Metastatic Non-Small-Cell Lung Cancer, Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing

DrugFurmonertinib

ArriVent BioPharma, Inc.

Phase 3

480

Ankara, Antalya, Istanbul

2025-12-17

Recruiting

Postoperative Pain Monitoring With ANI in Lumbar Spine Surgery

NCT07455565Postoperative Pain, Lumbar Spine Surgery

DrugMultimodal analgesia

Akdeniz University Hospital

Not applicable

100

Antalya

2025-12-16

Not yet open

The Effect of Artificial Intelligence-Supported Intramuscular and Subcutaneous Injection Training on Nursing Students

NCT07253571AI Chatbot, Nursing Education, AI (Artificial Intelligence), Nursing Skills

Akdeniz University

Not applicable

Antalya

2025-12-15

Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis

DrugsVepugratinib·Pembrolizumab

Eli Lilly and Company

Phase 3

450

Adana, Adapazarı, Ankara, Antalya, Diyarbakır, Edirne, Gaziantep, Istanbul

2025-12-12

Recruiting

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

NCT07241390Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease

DrugOrforglipron

Eli Lilly and Company

Phase 3

7,140

Adana, Afyonkarahisar, Ankara, Antalya, Çanakkale, Çorum, Eskişehir, Istanbul

2025-12-01

Recruiting

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms

Eli Lilly and Company

Phase 2

204

Adana, Ankara, Antalya, Bornova, Edirne, Gaziantep, Pendik, Sakarya

2025-11-28

Recruiting

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

NCT07211958Acute Myeloid Leukemias

DrugRevumenib

Syndax Pharmaceuticals

Phase 3

468

Şişli, Alsancak, Mezitli, Ankara, Antalya, Gaziantep

2025-11-25

Recruiting

An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

NCT07233213Primary Immune Thrombocytopenia (ITP)

Grand Shuyang Life Sciences (Chengdu) Co., Ltd.

Phase 3

Ankara, Malatya, Istanbul, Kayseri, Mersin, Antalya, Adana, Gaziantep

2025-11-24

Recruiting

AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

NCT07215585Large B-cell Lymphoma

DrugsR-mini-CHOP·Surovatamig

AstraZeneca

Phase 3

420

Ankara, Antalya, Istanbul, Izmir, Kocaeli

2025-11-11

Recruiting

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

NCT07186101Ulcerative Colitis

DrugsZotemtegrast·Mirikizumab

Eli Lilly and Company

Phase 2

252

Adana, Ankara, Antalya, Eskişehir, Hatay, İzmit, Malatya, Mersin

2025-11-10

Not yet open

Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion

NCT07160764Intrauterine Abnormalities in Infertility, Asherman Syndrome, Intra-uterine Adhesions, Postoperative Adhesion of Uterus

Semikal Technology

Observational

Antalya

2025-11-01

Recruiting

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

NCT07196722Crohn Disease

DrugIcotrokinra

Janssen Research & Development, LLC

Phase 2/3

1,092

Ankara, Antalya, Bursa, Istanbul, Izmir, Kocaeli, Mersin

2025-10-03

Active, closed

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

NCT07196748Colitis, Ulcerative

DrugIcotrokinra

Janssen Research & Development, LLC

Phase 3

896

Ankara, Antalya, Istanbul, Izmir, Kocaeli, Mersin

2025-10-01

Active, closed

SCT-Based Health Promotion in Older Adults

NCT06419465Health Promotion, Older Adults (65 Years and Older)

Akdeniz University

Not applicable

108

Antalya

2025-10-01

Recruiting

Effect of Bed Height on Chest Compression Quality and Provider Biomechanics During Pediatric CPR Simulation

NCT07329842Pediatric Cardiac Arrest (Simulated), Cardiopulmonary Resuscitation, Simulation Training, In-Hospital Cardiac Arrest, Rescuer Fatigue During CPR

Akdeniz University

Not applicable

Antalya

2025-09-28

Recruiting

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT07111520Non-small Cell Lung Cancer

DrugsBNT326·Pumitamig

BioNTech SE

Phase 1/2

880

Adana, Ankara, Antalya, Istanbul, Mersin, Sakarya

2025-09-22

Not yet open

Comparison of the Silverman-Andersen Score and the Downes Score

NCT07183956Respiratory Distress Neonatal, Noninvasive Ventilation, Intubation, Scoring Systems

Muğla Sıtkı Koçman University

Observational

220

Antalya, Muğla, Sanliurfa

2025-09-15

Recruiting

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

NCT07279402NSCLC Stage IV, PD-L1 Gene Mutation, Atezolizumab, Real World Study

Antalya Training and Research Hospital

Observational

150

Adana, Afyonkarahisar, Ankara, Antalya, Aydin, Diyarbakır, Edirne, Gaziantep

2025-09-15

Recruiting

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

NCT06911502Follicular Lymphoma

DrugsPrednisone/Prednisolone·Golcadomide·Bendamustine·Vincristine

Celgene

Phase 3

400

Istanbul- Fatih, Ankara, Antalya, Mersin

2025-07-28

Active, closed

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

NCT07037433Atherosclerotic Cardiovascular Disease, Overweight, Obesity

DrugMaridebart cafraglutide

Amgen

Phase 3

12,800

Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Denizli, Istanbul, Izmir

2025-07-25

Recruiting

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

NCT06758401Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)

DrugsSigvotatug vedotin·Pembrolizumab

Pfizer

Phase 3

714

Istanbul, Izmir, Ankara, Adana, Antalya, Diyarbakır, İstanbul - Fatih

2025-07-23

Recruiting

A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region

NCT07065344Hematology, Diffused Large B Cell Lymphoma

AstraZeneca

Observational

500

Ankara, Antalya, Istanbul, Izmir

2025-07-23

Recruiting

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT07064473Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases

DrugsVicadrostat·Dapagliflozin

Boehringer Ingelheim

Phase 3

11,800

Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Edirne, Istanbul, Izmir

2025-07-22

Active, closed

Possible Sarcopenia, Sarcopenia, and Functional Status in Patients With Primary Sjögren's Syndrome

NCT07804719Primary Sjögren Syndrome, Sarcopenia

Antalya Training and Research Hospital

Observational

120

Antalya

2025-07-20

Not yet open

The Effectiveness Of BETY In Fibromyalgia

NCT07034417Fibromyalgia

Aysima Barlak

Not applicable

Antalya

2025-07-12

Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

NCT07052903Transthyretin Amyloidosis With Cardiomyopathy

DrugNucresiran

Alnylam Pharmaceuticals

Phase 3

1,750

Ankara, Antalya, Istanbul

2025-07-02

Recruiting

The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation

NCT07294183Renal Transplantation

Akdeniz University

Not applicable

Antalya

2025-07-01

Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086Ulcerative Colitis, Obesity or Overweight

DrugsMirikizumab·Tirzepatide

Eli Lilly and Company

Phase 3

350

Ankara, Antalya, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit

2025-06-26

Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

NCT06959095Pulmonary Disease, Chronic Obstructive

DrugDepemokimab

GlaxoSmithKline

Phase 3

981

Izmir, Antalya, Denizli, Çanakkale, İzmit

2025-06-20

Active, closed

Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1

NCT07493525Myotonic Dystrophy Type 1, Falls

Antalya Training and Research Hospital

Observational

Antalya

2025-06-20

Recruiting

Inflammation Severity and miRNA-126 in Trauma

NCT07291908Trauma ICU Patients, Endothelial Injury

Melike Cengiz

Observational

130

Antalya

2025-06-17

Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

NCT07000357Cardiovascular Disease

DrugAZD0780

AstraZeneca

Phase 3

15,100

Afyonkarahisar, Ankara, Antalya, Çanakkale, Edirne, Istanbul, Izmir, Kayseri

2025-06-04

Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT06852222Leukemia, Myeloid, Acute

DrugsBleximenib·Azacitidine·Venetoclax

Janssen Research & Development, LLC

Phase 3

600

Ankara, Antalya, Istanbul, Mersin, Sakarya, Samsun

2025-06-04

Active, closed

Comfort Care Bundle

NCT07366021ICU, Comfort, Bundle Care, Nursing Care

Akdeniz University

Not applicable

Antalya

2025-06-01

Not yet open

Effects of Health Belief Model Interventions on Preventive Beliefs in Secondhand Smoke Exposure

NCT06683144Secondhand Smoke Exposure

Akdeniz University

Not applicable

Antalya

2025-06-01

Not yet open

The Effect of Virtual Reality Glasses on Sleep Quality and Anxiety Level in High-risk Pregnant Women

NCT06996457Virtual Reality, Pregnancy, Anxiety, Sleep Quality

Akdeniz University

Not applicable

Antalya

2025-06-01

Not yet open

Evaluation of Mobile Education Program in Patients With Atrial Fibrillation.

NCT07030335Atrial Fibrillation (AF)

Akdeniz University

Not applicable

Antalya

2025-06

Active, closed

The Effect of a Breastfeeding and Infant Care Education Program Prepared According to Mercer Theory on Breastfeeding Self-Efficacy, Readiness for Infant Care, and Acceptance of the Maternal Role

NCT07121465Pregnancy, Breastfeeding, Infant Care, Newborn Care

Antalya Bilim University

Not applicable

142

Antalya

2025-05-30

Recruiting

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

NCT06935357Immunoglobulin A Nephropathy (IgAN)

DrugFelzartamab

Biogen

Phase 3

454

İzmit, Ankara, Istanbul, Sanliurfa, Antalya, Kayseri, Konya

2025-05-08

Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT06499285Myelodysplastic Syndromes

DrugElritercept

Takeda

Phase 3

225

Adana, Ankara, Antalya, Mersin, Sakarya, Samsun

2025-05-06

Not yet open

Electronic Patient Decision Support System for Patients with Type 2 Diabetes (DiaPaDeSS)

NCT05902156Mobile Health, Type 2 Diabetes, Patient Activation, Self-Management

Akdeniz University

Not applicable

Antalya

2025-03-30

Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

NCT06890598Carcinoma, Non-Small-Cell Lung

DrugsOlomorasib·Durvalumab·Pembrolizumab

Eli Lilly and Company

Phase 3

700

Adana, Adapazarı, Ankara, Antalya, Edirne, Gaziantep, Istanbul, Izmir

2025-03-27

Active, closed

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

NCT06788912Lung Neoplasm Malignant

DrugsSteroid mouthwash (dexamethasone·Acetaminophen·Ribociclib·Paraplatin

Merck Sharp & Dohme LLC

Phase 2

Adana, Ankara, Antalya, Izmir, Samsun

2025-03-20

Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

NCT06677060Heart Failure

DrugBaxdrostat/dapagliflozin

AstraZeneca

Phase 3

11,300

Adana, Afyonkarahisar, Ankara, Antalya, Eskişehir, Istanbul, Izmir, Kahramanmaraş

2025-03-14

Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

NCT06742723Chronic Kidney Disease and Hypertension

DrugBaxdrostat/dapagliflozin

AstraZeneca

Phase 3

5,000

Adana, Adapazarı, Altındağ, Ankara, Antalya, Haliliye, Kahramanmaraş, Kayseri

2025-03-03

Recruiting

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

NCT06841055Non-small Cell Lung Cancer

DrugsPumitamig·Docetaxel

BioNTech SE

Phase 2

Adana, Ankara, Antalya, Istanbul, Zeytinburnu

2025-03-03

Not yet open

Craniocervical Dysfunction Index in Patients With Temporomandibular Joint Dysfunction

NCT06655753Temporomandibular Joint Dysfunction, Craniocervical Dysfunction, Reliability, Validity

Alanya Alaaddin Keykubat University

Observational

Antalya

2025-03-01

Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

NCT06764875HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

DrugsRilvegostomig·Trastuzumab deruxtecan·Trastuzumab·Adrucil

AstraZeneca

Phase 3

840

Ankara, Antalya, Diyarbakır, Erzurum, Istanbul, Izmir, Mezitli

2025-03-01

Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

NCT06767514Non-Small Cell Lung Cancer

DrugsIvonescimab·Pembrolizumab

Summit Therapeutics

Phase 3

780

Istanbul, Ankara, Adana, Antalya, Diyarbakır, Gaziantep, Izmir, İzmit

2025-02-27

Recruiting

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

NCT06712355Extensive-stage Small-cell Lung Cancer

DrugsPumitamig·Etoposide·Atezolizumab·Carboplatin

BioNTech SE

Phase 3

621

Adana, Ankara, Antalya, Edirne, Istanbul, Izmir, Kocaeli, Mamak

2025-02-03

Active, closed

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

NCT06812325Thyroid Eye Disease (TED)

DrugVRDN-003

Viridian Therapeutics, Inc.

Phase 3

320

Ankara, Antalya, Istanbul

2025-02-03

Not yet open

Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with Endometrial Cancer

NCT06781216Endometrium Cancer, Post Traumatic Stress Symptoms, Post Traumatic Growth, Psychological

Akdeniz University

Not applicable

Antalya

2025-02-03

Recruiting

The Effect of Education Given to Type 2 Diabetics on Diabetes Self-management, Health Fatalism and Metabolic Parameters

NCT06769477Type 2 Diabetes, Type 2 Diabetes Patients

Ataturk University

Not applicable

Antalya

2025-02-01

Recruiting

Telerehabilitation-Based Coaching Interventions (TeleSCoP) for Patients With Ischemic Stroke

NCT05940350Ischemic Stroke, Coaching

Akdeniz University

Not applicable

Antalya

2025-02-01

Recruiting

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma

DrugsFicerafusp alfa·Keytruda·Pembrolizumab

Bicara Therapeutics

Phase 2/3

650

Ankara, Antalya, Istanbul, Izmir

2025-01-28

Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

NCT06717347Diffuse Large B-Cell Lymphoma

DrugsRituximab Biosimilar·Zilovertamab vedotin·Riabni·Ruxience

Merck Sharp & Dohme LLC

Phase 3

1,046

Korfez Mahallesi, Suleymanpasa, Adana, Ankara, Antalya, Istanbul

2025-01-27

Active, closed

Effectiveness and Safety of Intra-articular SEMICAL GEL-B CROSS Therapy in Knee Osteoarthritis (SEM-ART1)

NCT06141018Knee Osteoarthritis

Semikal Technology

Not applicable

102

Antalya

2025-01-15

Recruiting

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

NCT06712316Non-small Cell Lung Cancer

DrugsPumitamig·Pemetrexed·Paclitaxel·Carboplatin

BioNTech SE

Phase 2/3

1,580

Adana, Ankara, Antalya, Diyarbakır, Gaziantep, Istanbul, Izmir, Kadıköy

2025-01-07

Recruiting

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT06588478Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

DrugPirtobrutinib

Loxo Oncology, Inc.

Phase 2

249

Adapazarı, Ankara, Antalya, Istanbul, Izmir, İzmit, Mersin, Samsun

2025-01-03

Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

NCT06750094Colorectal Neoplasms

DrugsLeucovorin calcium/Levoleucovorin·Amivantamab·Erbitux·Avastin

Janssen Research & Development, LLC

Phase 3

700

Adana, Ankara, Antalya, Edirne, Istanbul, Konya, Sakarya

2024-12-12

Active, closed

Evaluation of Salivary and Serum Levels of TNF-α, IL-17A, and YKL-40 in Individuals With Psoriasis

NCT06984237Periodontitis, Psoriasis

Akdeniz University

Observational

100

Antalya

2024-12-02

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

NCT06627647Non-squamous Non-small Cell Lung Cancer

DrugsRilvegostomig·Pemetrexed·Keytruda·Cisplatin

AstraZeneca

Phase 3

1,160

Ankara, Antalya, Edirne, Izmir, Seyhan

2024-11-27

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

NCT06692738Non-small Cell Lung Cancer

DrugsRilvegostomig·Nab-paclitaxel·Keytruda·Paclitaxel

AstraZeneca

Phase 3

1,160

Ankara, Antalya, Istanbul, Yenimahalle

2024-11-18

Active, closed

Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy Controls

NCT06897722Psoriasis (PsO), Periodontal Disease

Zhala Vatankha Sain

Observational

100

Antalya

2024-11-04

Active, closed

The Prevalance of Malnutrition and Its Association With Disability in Patients With Relapsing-Remitting Multiple Sclerosis

NCT07497126Relapsing Remitting Multiple Sclerosis (RRMS), Malnutrition or Risk of Malnutrition

Antalya Training and Research Hospital

Observational

169

Antalya

2024-11-04

Active, closed

Performance and Safety of Semical Dermal Fillers in Facial Rejuvenation

NCT07160777Facial Aging, Skin Rejuvenation, Volume Defects in the Mid-face, Lip Augmentation and Correction of Perioral Rhytids

Semikal Technology

Observational

Antalya

2024-11-01

Active, closed

fNIRS-based Analysis and Evaluation of the Effect of Schroth Rehabilitation on Motor Functions in Adolescent Idiopathic Scoliosis (AIS)

NCT06884150Scoliosis Idiopathic, Scoliosis; Adolescence

Akdeniz University

Not applicable

Antalya

2024-10-01

Active, closed

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

NCT06238622Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

DrugNerandomilast

Boehringer Ingelheim

Phase 3

1,666

Ankara, Antalya, Çapa, Yenimahalle/ANKARA

2024-09-26

By invitation

Mobile Education and Telephone Monitoring for ICD Patients: Effects on Anxiety, Acceptance, and Self-Efficacy

NCT06935526Patient Acceptance of Health Care, Nursing, Implantable Cardioverter Defibrillator (ICD), Self-Efficacy

Akdeniz University

Not applicable

Antalya

2024-09-26

Active, closed

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

NCT06525220Head and Neck Squamous Cell Carcinoma

DrugsPetosemtamab·Pembrolizumab

Genmab

Phase 3

699

Ankara, Antalya, Istanbul

2024-09-25

Active, closed

A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

NCT06557772Coeliac Disease, Celiac Disease

DrugAmlitelimab

Sanofi

Phase 2

229

Antalya, Gaziantep, Istanbul, Izmir, Mersin, Sanliurfa

2024-08-29

Active, closed

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

NCT06450197Moderate to Severe Crohn's Disease

DrugAZD7798

AstraZeneca

Phase 2

120

Ankara, Antalya, Izmir, İzmit, Malatya

2024-08-28

Recruiting

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

NCT06467357Biliary Tract Cancer

DrugsRilvegostomig·Trastuzumab deruxtecan·Durvalumab·Gemcitabine

AstraZeneca

Phase 3

620

Altındağ, Antalya, Istanbul, Izmir, Mezitli, Yakutiye

2024-08-12

Active, closed

The Effect of Percutaneous Dilatational Tracheostomy on Intracranial Pressure

NCT06779877Intracranial Pressure Change, Tracheostomy

Akdeniz University

Observational

Antalya

2024-08-01

Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

NCT06282575Biliary Tract Cancer

DrugsZanidatamab·Durvalumab·Gemcitabine·Cisplatin

Jazz Pharmaceuticals

Phase 3

286

Istanbul, Ankara, Antalya, Edirne

2024-07-19

Active, closed

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

NCT06456346Essential Thrombocythemia

DrugsBomedemstat·Hydroxyurea

Merck Sharp & Dohme LLC

Phase 3

300

Bornova, Ankara, Antalya, Edirne, Istanbul, Kocaeli, Samsun

2024-07-16

Active, closed

PVP-Guided Decongestive Therapy in HF 2

NCT06495892Heart Failure, Congestion, Congestive Heart Failure

Başakşehir Çam & Sakura City Hospital

Phase 4

650

Ankara, Antalya, Edirne, Erzurum, Eskişehir, Istanbul, Izmir, Kahramanmaraş

2024-07-01

Active, closed

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

NCT06118281Cardiovascular Risk, Acute Myocardial Infarction (AMI)

DrugZiltivekimab

Novo Nordisk A/S

Phase 3

10,000

Ankara, Istanbul, Eskişehir, Afyonkarahisar, Antalya, Bursa, Edirne, Kayseri

2024-06-25

Recruiting

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

NCT06430801Crohn's Disease

DrugTulisokibart

Merck Sharp & Dohme LLC

Phase 3

1,200

Bornova, Ankara, Antalya, Eskişehir, Istanbul, Kocaeli

2024-06-05

Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

NCT06112314Advanced Melanoma

DrugsBrenetafusp·Relatlimab·Opdivo·Nivolumab

Immunocore Ltd

Phase 3

680

Yüreğir, Çankaya, Kepez, Antalya, Şehitkamil, Bahçelievler, Bornova, Cordaleo

2024-06-05

Recruiting

Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)

NCT07737340HIV Infections, Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH), Fatty Liver

Yaşar Bayındır, MD

Observational

411

Ankara, Adana, Antalya, Diyarbakır, Gaziantep, Istanbul, Izmir, Kocaeli

2024-06-01

Active, closed

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06158841Multiple Myeloma

DrugsElotuzumab·Etentamig·Carfilzomib·Selinexor

AbbVie

Phase 3

421

Şişli, Ankara, Antalya, Edirne, Istanbul

2024-05-19

Active, closed

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

NCT06407934Dermatitis Atopic

DrugAmlitelimab

Sanofi

Phase 3

1,541

Antalya, Istanbul, Kayseri, Mersin, Samsun

2024-05-08

Active, closed

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT06383390Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)

DrugRetatrutide

Eli Lilly and Company

Phase 3

10,000

Afyonkarahisar, Ankara, Antalya, Bornova, Çorum, Edirne, Eskişehir, Gaziantep

2024-04-30

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

NCT05485961End Stage Kidney Disease

DrugClazakizumab

CSL Behring

Phase 2/3

3,110

Ankara, Antalya, Atakum, Bakırköy, Bornova, Edirne, Gaziantep, İzmit

2024-04-27

Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

NCT06307652Heart Failure and Impaired Kidney Function

AstraZeneca

Phase 3

3,850

Adana, Ankara, Antalya, Bursa, Center, Dinar, Eskişehir, Istanbul

2024-04-12

Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

NCT06357533Non-Small Cell Lung Cancer

DrugsRilvegostomig·Dato-DXd·Keytruda·Pembrolizumab

AstraZeneca

Phase 3

675

Adapazarı, Ankara, Antalya, Diyarbakır, Istanbul

2024-04-11

Active, closed

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

NCT06268873Chronic Kidney Disease and Hypertension

DrugBaxdrostat/dapagliflozin

AstraZeneca

Phase 3

2,554

Adana, Adapazarı, Afyonkarahisar, Ankara, Antalya, Bursa, Istanbul, Kahramanmaraş

2024-03-29

Recruiting

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

NCT06256588Neoplasms, Head and Neck

DrugDostarlimab

GlaxoSmithKline

Phase 3

864

Adapazarı, Ankara, Antalya, Istanbul

2024-03-21

Active, closed

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

NCT05827081Early Breast Cancer

DrugsLeuprolide·Goserelin·Exemestane·Ribociclib

Novartis Pharmaceuticals

Phase 3

1,466

Sakarya, Ankara, Istanbul, Izmir, Denizli, Antalya, Diyarbakır, Adana

2024-02-28

Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

NCT06283966COPD (Chronic Obstructive Pulmonary Disease)

AstraZeneca

Phase 3

5,250

Adana, Afyonkarahisar, Antalya, Bursa, Çanakkale, Çankaya, Isparta, Istanbul

2024-02-21

Recruiting

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

NCT06174987Advanced Cancer, Metastatic Cancer

DrugTrastuzumab deruxtecan

Daiichi Sankyo

Phase 3

Adana, Ankara, Antalya, Diyarbakır, Istanbul, Tekirdağ

2024-01-05

Active, closed

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

NCT06079879Essential Thrombocythemia

DrugsAnagrelide·Bomedemstat·Busulfan·Ruxolitinib

Merck Sharp & Dohme LLC

Phase 3

340

Bornova, Ankara, Antalya, Edirne, Istanbul, Kocaeli, Mersin, Samsun

2023-12-31

Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

NCT06119581Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

DrugsOlomorasib·Pemetrexed·Cisplatin·Carboplatin

Eli Lilly and Company

Phase 3

1,264

Adana, Ankara, Antalya, Bursa, Diyarbakır, Istanbul, Izmir, Kocaeli

2023-12-21

Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

NCT06129864Locally Advanced Head and Neck Squamous Cell Carcinoma

DrugVolrustomig

AstraZeneca

Phase 3

1,145

Ankara, Antalya, Cordaleo, Eskişehir, Istanbul, Yenimahalle

2023-12-14

Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

NCT06136559Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

DrugsNemtabrutinib·Ibrutinib·Acalabrutinib

Merck Sharp & Dohme LLC

Phase 3

1,200

Ankara, Antalya, Edirne, Istanbul, Izmir, Samsun

2023-12-13

Active, closed

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

NCT06109779Biliary Tract Cancer

DrugsGemcitabine/Cisplatin·Rilvegostomig·Teysuno·Capecitabine

AstraZeneca

Phase 3

760

Ankara, Antalya, Erzurum, Fatih-Istanbul, Samsun

2023-12-04

By invitation

Video-immunotherapy: a New Approach in Breast Cancer Treatment

NCT07357207Female Breast Cancer Patients

Izmir Biomedicine and Genome Center

Not applicable

Izmir, Antalya

2023-12-01

Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

NCT05920356Non-Small Cell Lung Cancer (NSCLC)

DrugsLumakras·Sotorasib·Pembrolizumab

Amgen

Phase 3

750

Adana, Ankara, Antalya, Aydin, Denizli, Istanbul, Izmir, Samsun

2023-11-16

Active, closed

A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

NCT06063967Crohn's Disease

DrugsSkyrizi·Risankizumab

AbbVie

Phase 3

289

Yenimahalle, Dilovası, Ankara, Antalya, Izmir, Mersin

2023-11-15

Active, closed

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

NCT05925803Systemic Sclerosis, Scleroderma

AstraZeneca

Phase 3

314

Ankara, Antalya, Center, Kazımkarabekir, Kocaeli

2023-11-08

Active, closed

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT06052059Ulcerative Colitis

DrugTulisokibart

Merck Sharp & Dohme LLC

Phase 3

1,109

Istanbul- Fatih, Ankara, Antalya, Edirne, Eskişehir, Istanbul, Kocaeli

2023-10-25

Active, closed

A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.

NCT05984277Metastatic Non-small Cell Lung Cancer

DrugsVolrustomig·Pemetrexed·Paclitaxel·Carboplatin

AstraZeneca

Phase 3

895

Ankara, Antalya, Çankaya, Diyarbakır, Fatih-Istanbul, Istanbul, Izmir, Pamukkale

2023-10-24

Recruiting

Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

NCT05879757Multiple Myeloma, Secondary Immunodeficiency (SID)

Takeda

Observational

Ankara, Antalya, Istanbul

2023-10-17

Active, closed

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

NCT06008756Arteriosclerosis, Hypercholesterolaemia

DrugEnlicitide Decanoate

Merck Sharp & Dohme LLC

Phase 3

14,550

Altindağ, Bornova, Cordaleo, Melikgazi, Adana, Ankara, Antalya, Çanakkale

2023-10-09

Active, closed

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

NCT05952557Breast Cancer, Early Breast Cancer

DrugsCamizestrant·Tamoxifen·Exemestane·Anastrozole

AstraZeneca

Phase 3

5,511

Ankara, Antalya, Bursa, Çiğli, Istanbul, Samsun

2023-10-05

Recruiting

TDCS Stimulation After Covid-19 Infection

NCT06183424COVID-19

Istanbul Medipol University Hospital

Not applicable

Antalya

2023-10-01

Active, closed

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

NCT06037252Type 2 Diabetes, Obesity

DrugTirzepatide

Eli Lilly and Company

Phase 2

414

Kadıköy, Adana, Antalya, Bursa, Diyarbakır, Gaziantep, Istanbul, Samsun

2023-09-21

Active, closed

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

NCT05946941Sjögren's Syndrome

DrugDeucravacitinib

Bristol-Myers Squibb

Phase 3

774

Yenimahalle, Ankara, Antalya, Istanbul

2023-09-11

Recruiting

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

DrugOlverembatinib

Ascentage Pharma Group Inc.

Phase 3

350

Ankara, Antalya, Istanbul, Izmir, Kayseri, Mersin, Samsun, Tekirdağ

2023-08-31

Recruiting

The Effects of Specific tDCS on Cognition in MCI

NCT05919485Alzheimer Disease, Parkinson Disease

Istanbul Medipol University Hospital

Not applicable

120

Antalya

2023-08-01

Active, closed

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT05843643Systemic Lupus Erythematosus

DrugUpadacitinib

AbbVie

Phase 3

1,014

Sihhiye, Ankara, Yenimahalle, Şehitkamil, Antalya, Istanbul, Meram Konya, Trabzon

2023-07-25

Active, closed

Effect of Chlorhexidine Gluconate Hair Bath on the Development of Surgical Site Infection and Time to Discharge

NCT06763211Infection Secondary to Surgical Procedure

HAVVA ÇOŞKUN

Not applicable

Antalya

2023-07-24

Active, closed

A Study of Zigakibart in Adults With IgA Nephropathy

NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy

DrugZigakibart

Novartis Pharmaceuticals

Phase 3

383

Bornova, İzmit, Antalya, Kayseri

2023-07-06

Active, closed

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

NCT05671510Non Small Cell Lung Cancer

DrugsGotistobart·Taxotere·Docetaxel

OncoC4, Inc.

Phase 3

630

Adana, Ankara, Antalya, Edirne, Fatih, Istanbul, Izmir

2023-06-28

Active, closed

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

NCT05757102Asthma

DrugFF/UMEC/VI

GlaxoSmithKline

Phase 3

138

Adana, Antalya, Istanbul

2023-04-24

Active, closed

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

NCT05757869Atrial Fibrillation

DrugsMilvexian·Apixaban

Janssen Research & Development, LLC

Phase 3

20,284

Afyonkarahisar, Ankara, Antalya, Istanbul, Izmir, Kayseri, Mersin, Samsun

2023-04-11

Active, closed

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

NCT05572515Multiple Myeloma

DrugsTeclistamab·Carfilzomib·Pomalidomide·Bortezomib

Janssen Research & Development, LLC

Phase 3

614

Ankara, Antalya, Denizli, Istanbul, Samsun

2023-03-29

Active, closed

A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

NCT05654623Advanced Breast Cancer

DrugsVepdegestrant·Fulvestrant

Pfizer

Phase 3

624

Altindağ, Istanbul, Izmir, Adana, Ankara, Antalya, Edirne, Samsun

2023-03-03

Active, closed

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A

NCT05685238Haemophilia A, Haemophilia A With Inhibitors

Novo Nordisk A/S

Phase 3

451

Ankara, Capa-ISTANBUL, Antalya, Adana, Bornova-IZMIR, Edirne

2023-02-13

Active, closed

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

NCT05748600Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack

DrugDexpramipexole Dihydrochloride

Areteia Therapeutics

Phase 3

600

Adana, Ankara, Antalya, Bornova, Center, Istanbul, Konak, Mersin

2023-01-30

Active, closed

ABTECT - Maintenance

NCT05535946Ulcerative Colitis

DrugObefazimod

Abivax S.A.

Phase 3

1,116

Ankara, Antalya, Istanbul, Kocaeli, Malatya

2023-01-16

Active, closed

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

NCT05620407Systemic Lupus Erythematosus

DrugDeucravacitinib

Bristol-Myers Squibb

Phase 3

513

Ankara, Antalya, Gaziantep

2023-01-12

Active, closed

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

NCT05555732Metastatic Non Small Cell Lung Cancer

DrugsDato-DXd·Pemetrexed·Keytruda·Cisplatin

Daiichi Sankyo

Phase 3

1,170

Ankara, Antalya, Bağcılar, Bornova-Izmir, Cankaya/Ankara, Etimesgut Ankara, Istanbul, Seyhan

2023-01-11

Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

NCT05712200Atrial Fibrillation (AF)

DrugAbelacimab

Anthos Therapeutics, Inc.

Phase 3

2,500

Adana, Istanbul, Pendik, Izmir, Ankara, Antalya, Bursa, Diyarbakır

2022-12-27

Active, closed

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

NCT05567796Obesity

DrugsCagrilintide·Semaglutide

Novo Nordisk A/S

Phase 3

3,400

Ankara, Sultangazi, Adana, Antalya, Hatay, Istanbul, Sivas

2022-11-01

Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

NCT05552222Multiple Myeloma

DrugsTalquetamab·Teclistamab·Daratumumab·Lenalidomide

Janssen Research & Development, LLC

Phase 3

1,590

Ankara, Antalya, Denizli, Istanbul, Izmir, Samsun

2022-10-25

Active, closed

A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer

NCT05565378Lung Cancer, Non-Small Cell

DrugsNelistotug·Belrestotug·Dostarlimab·Pembrolizumab

GlaxoSmithKline

Phase 2

351

Samsun, Ankara, Antalya, Istanbul

2022-10-14

Active, closed

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

NCT05455320Multiple Myeloma

DrugsTalquetamab·Pomalidomide·Daratumumab·Dexamethasone

Janssen Research & Development, LLC

Phase 3

864

Ankara, Antalya, Istanbul, Izmir, Samsun

2022-10-13

Active, closed

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

NCT05556512Obesity, Overweight

DrugTirzepatide

Eli Lilly and Company

Phase 3

15,374

Adana, Ankara, Antalya, Aydin, Balçova, Bornova, Denizli, Gaziantep

2022-10-11

Active, closed

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

NCT05514054Breast Neoplasms

DrugsImlunestrant·Tamoxifen·Exemestane·Anastrozole

Eli Lilly and Company

Phase 3

8,000

Adana, Adapazarı, Altindağ, Ankara, Antalya, Bursa, Diyarbakır, Edirne

2022-10-04

Active, closed

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

NCT05409066Follicular Lymphoma (FL)

DrugsEpcoritamab·Lenalidomide·Rituximab

Genmab

Phase 3

549

Ankara, Antalya, Diyarbakır, Istanbul, Izmir, Kocaeli, Samsun

2022-09-20

Active, closed

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

NCT05492578Dermatitis Atopic

DrugAmlitelimab

Sanofi

Phase 2/3

1,856

Antalya, Gaziantep, Istanbul, Kayseri

2022-08-22

Active, closed

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia

NCT05426733Biliary Atresia

DrugOdevixibat

Albireo, an Ipsen Company

Phase 3

180

Ankara, Antalya, Istanbul

2022-07-05

Active, closed

A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

NCT05181618Severe Hemophilia A, Moderate Hemophilia A

DrugEmicizumab

Hoffmann-La Roche

Phase 4

136

Ankara, Antalya, Istanbul, Izmir

2022-06-20

Recruiting

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

NCT05183646FSGS

DrugRepagermanium

Dimerix Bioscience Pty Ltd

Phase 3

286

Ankara, Antalya, Bursa, Edirne, Erciyes, Istanbul, Kocaeli

2022-05-30

Active, closed

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

NCT05155254Metastatic Melanoma, Unresectable Melanoma

DrugsIO102-IO103·Pembrolizumab

IO Biotech

Phase 3

407

Adana, Ankara, Antalya, Bornova, Istanbul

2022-05-17

Active, closed

Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

NCT05215340Metastatic Non Small Cell Lung Cancer

DrugsDato-DXd·Keytruda·Pembrolizumab

Daiichi Sankyo

Phase 3

740

Adana, Antalya, Bornova-İzmir, Çankaya, Istanbul, Seyhan /Adana

2022-03-04

Active, closed

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

NCT05211895Non-Small Cell Lung Cancer

DrugsDomvanalimab·Durvalumab

AstraZeneca

Phase 3

791

Adapazarı, Ankara, Antalya, Çankaya, Edirne, Istanbul, Izmir, Konya

2022-02-18

Active, closed

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

NCT05173987Endometrial Neoplasms

DrugsTaxotere·Platinol-AQ·Paraplatin·Taxol

Merck Sharp & Dohme LLC

Phase 3

280

Fatih, Ankara, Antalya, Istanbul

2022-02-03

Recruiting

Acute Myeloid Leukemia Registry

NCT05979675Acute Myeloid Leukemia

Turkish Hematology Association

Observational

250

Antalya

2021-12-21

Active, closed

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

NCT04819100Carcinoma, Non-Small-Cell Lung

DrugSelpercatinib

Eli Lilly and Company

Phase 3

152

Bornova, Izmir, Karsiyaka, Adana, Ankara, Antalya, Bursa, Diyarbakır, Edirne

2021-12-20

Active, closed

A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)

NCT04770753Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia

DrugMitapivat

Agios Pharmaceuticals, Inc.

Phase 3

194

Adana, Antalya, Balcalı, Bornova, Fatih, Mersin

2021-12-20

Active, closed

A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

NCT04770779Transfusion-dependent Alpha-Thalassemia, Transfusion-dependent Beta-Thalassemia

DrugMitapivat

Agios Pharmaceuticals, Inc.

Phase 3

258

Adana, Antalya, Balcalı, Bornova, Fatih, Mersin

2021-11-30

Active, closed

Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia

NCT04994717Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

DrugBlinatumomab

Amgen

Phase 3

303

Ankara, Antalya, Istanbul, Izmir, Samsun

2021-11-02

Recruiting

ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices

NCT05174442Heart Diseases

Occlutech International AB

Observational

685

Adana, Malatya, Izmir, Aydin, Istanbul, Antalya, Karaman, Diyarbakır

2021-10-14

Active, closed

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

NCT04975308Breast Neoplasms, Neoplasm Metastasis

DrugsImlunestrant·Exemestane·Abemaciclib·Fulvestrant

Eli Lilly and Company

Phase 3

874

Stanbul, Üsküdar / Stanbul, Adana, Ankara, Antalya, Diyarbakır, Edirne, Istanbul

2021-10-04

Recruiting

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

NCT05020236Multiple Myeloma

DrugsDarzalex·Elranatamab·Pomalidomide·Daratumumab

Pfizer

Phase 3

893

Istanbul, Izmir, Adana, Ankara, Antalya, Gaziantep, Kayseri, Kocaeli

2021-10-04

Recruiting

International Rare And Severe Psoriasis Expert Network

NCT04359394Pustular Psoriasis (PP)

University Hospital, Basel, Switzerland

Observational

180

Antalya, Edirne

2021-09-22

Recruiting

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

NCT04557462Primary IgA Nephropathy

DrugIptacopan

Novartis Pharmaceuticals

Phase 3

540

Istanbul, Köseköy, Antalya, Kayseri, Ankara, Mersin

2021-09-20

Active, closed

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

NCT04929210Arthritis, Psoriatic

DrugsTremfya·Guselkumab

Janssen Research & Development, LLC

Phase 4

411

Adana, Ankara, Antalya, Bursa, Istanbul, Konya

2021-08-30

Active, closed

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

NCT04961996Early Breast Cancer

DrugGiredestrant

Hoffmann-La Roche

Phase 3

4,170

Sariçam, Ankara, Antalya, Edirne, Istanbul, Izmir, Kocaeli, Samsun

2021-08-27

By invitation

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction

NCT04957719Acute Myocardial Infarction

Viatris Innovation GmbH

Phase 3

25,000

Afyonkarahisar, Antalya, Edirne, Eskişehir, Istanbul, Karabük, Malatya, Samsun

2021-08-14

Active, closed

Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin

NCT04960709Muscle Invasive Bladder Cancer

DrugsEnfortumab Vedotin·Tremelimumab·Durvalumab

AstraZeneca

Phase 3

712

Adana, Ankara, Antalya, Cordaleo, Edirne, Istanbul

2021-08-05

Active, closed

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

NCT04629248Primary Membranous Nephropathy

DrugsDiphenhydramine·Acetaminophen·Tacrolimus·Methylprednisolone

Hoffmann-La Roche

Phase 3

142

Ankara, Antalya, Izmir

2021-06-25

Active, closed

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

NCT04895358Breast Neoplasms

DrugsLiposomal doxorubicin·Abraxane·Xeloda·Taxol

Merck Sharp & Dohme LLC

Phase 3

342

Bornova, Izmir, Karsiyaka, Adana, Ankara, Antalya, Istanbul, Malatya

2021-06-18

Active, closed

An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib

NCT04764188NSCLC

DrugAlectinib

Hoffmann-La Roche

Observational

800

Adana, Ankara, Antalya, Denizli, Edirne, Istanbul, Izmir, Malatya

2021-05-10

Active, closed

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

NCT04862663Locally Advanced (Inoperable) or Metastatic Breast Cancer

DrugsCapivasertib·Ribociclib·Abemaciclib·Palbociclib

AstraZeneca

Phase 3

893

Ankara, Antalya, Cordaleo, Goztepe Istanbul, Malatya, Samsun

2021-05-10

Active, closed

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

NCT04873362Breast Cancer

DrugsTrastuzumab emtansine·Herceptin·Tecentriq·Trastuzumab

Hoffmann-La Roche

Phase 3

1,188

Adana, Ankara, Antalya, Bornova, ?zm?r, Diyarbakır, Edirne, Istanbul, Izmir

2021-05-04

Active, closed

Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine

NCT05092776Familial Mediterranean Fever, FMF

DrugRPH-104

R-Pharm International, LLC

Phase 2

Ankara, Antalya, Istanbul

2021-04-29

Active, closed

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis

DrugsPelabresib·Ruxolitinib

Novartis Pharmaceuticals

Phase 3

430

Ankara, Antalya, Edirne, Gaziantep, Izmir, Kayseri, Kocaeli, Mersin

2021-04-09

Active, closed

Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

NCT04644575Hemophilia A

DrugEfanesoctocog alfa

Bioverativ, a Sanofi company

Phase 3

261

Antalya, Istanbul, Izmir

2021-02-23

Active, closed

Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy

NCT04655976Lung Cancer, Non-Small Cell

DrugsCobolimab·Dostarlimab·Docetaxel

GlaxoSmithKline

Phase 2/3

758

Adana, Antalya, Izmir

2020-12-08

Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

NCT04613596Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

DrugsAdagrasib·Pembrolizumab

Mirati Therapeutics Inc.

Phase 2/3

626

Alanya, Altındağ, Ankara, Antalya, Atakum, Bahçelievler, Bornova, Çankaya

2020-12-02

Active, closed

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

NCT04576455Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

DrugsGiredestrant·Fulvestrant

Hoffmann-La Roche

Phase 2

303

Ankara, Antalya, Diyarbakır, Istanbul, Izmir, Samsun

2020-11-27

Active, closed

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

NCT04401748Myelodysplastic Syndrome (MDS)

DrugsVenclexta·Azacitidine·Venetoclax

AbbVie

Phase 3

531

Melikgazi, Ankara, Antalya, Samsun, Tuzla

2020-09-10

Active, closed

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

NCT04493853Hormone-Sensitive Prostate Cancer

DrugsZytiga·Capivasertib·Abiraterone acetate

AstraZeneca

Phase 3

1,012

Ankara, Antalya, Eskişehir, Istanbul, Izmir, Kayseri

2020-07-13

Active, closed

A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

NCT03992430Muscular Dystrophy, Duchenne

DrugEteplirsen

Sarepta Therapeutics, Inc.

Phase 3

160

Antalya, Mersin

2020-07-13

Active, closed

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

NCT04273945Pulmonary Arterial Hypertension

DrugMacitentan

Actelion

Phase 3

935

Adana, Ankara, Antalya, Bursa, Denizli, Istanbul, Izmir, Kartal Istanbul

2020-06-30

Active, closed

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

NCT04232553Crohn's Disease

DrugMirikizumab

Eli Lilly and Company

Phase 3

996

Ankara, Antalya, Bursa, Edirne, Eskişehir, Antakya, Istanbul, Istanbul- Fatih

2020-06-22

Active, closed

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

NCT04223856Urothelial Cancer

DrugsEnfortumab Vedotin·Keytruda·Gemcitabine·Cisplatin

Astellas Pharma Global Development, Inc.

Phase 3

886

Ankara, Antalya, Edirne, Istanbul, Konya, Malatya

2020-03-30

Active, closed

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

NCT04194944Non-Small Cell Lung Cancer

DrugsSelpercatinib·Pemetrexed·Cisplatin·Carboplatin

Eli Lilly and Company

Phase 3

261

Bornova, Adana, Ankara, Antalya, Diyarbakır, Edirne, Istanbul, Izmir

2020-02-17

Active, closed

A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)

NCT04161898Takayasu Arteritis (TAK)

DrugsUpadacitinib·Prednisolone

AbbVie

Phase 3

Ankara, Antalya, Istanbul, Izmir, Meram Konya

2020-02-04

Active, closed

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors

NCT04083781Haemophilia A With Inhibitors, Haemophilia B With Inhibitors

DrugConcizumab

Novo Nordisk A/S

Phase 3

134

Capa-ISTANBUL, Antalya, Adana

2019-10-21

Active, closed

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

NCT03958877Multiple Sclerosis, Relapsing-Remitting

DrugsPlegridy·Avonex

Biogen

Phase 3

152

Ankara, Antalya, Izmir, Samsun

2019-10-18

Active, closed

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

NCT03950232Ulcerative Colitis

DrugEtrasimod

Pfizer

Phase 3

896

Ankara, Antalya, Bursa, Kocaeli

2019-09-05

Active, closed

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

NCT03748641Castration-Resistant Prostatic Cancer

DrugsAbiraterone acetate·Niraparib·Prednisone

Janssen Research & Development, LLC

Phase 3

765

Adana, Ankara, Antalya, Edirne, Istanbul, Izmir, Kocaeli

2019-01-25

Active, closed

Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)

NCT03742895Advanced Solid Neoplasms

DrugOlaparib

Merck Sharp & Dohme LLC

Phase 2

329

Konya, Adana, Ankara, Antalya, Edirne, Istanbul, Izmir

2018-12-12

Active, closed

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

NCT03539536Non-small Cell Lung Cancer

DrugTelisotuzumab vedotin

AbbVie

Phase 2

270

Adana, Ankara, Antalya, Edirne, Istanbul, Istanbul, Izmir

2018-10-10

Active, closed

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

NCT03703297Small Cell Lung Cancer

DrugsTremelimumab·Durvalumab

AstraZeneca

Phase 3

730

Adana, Ankara, Antalya, Edirne, Istanbul, Izmir, Konya, Samsun

2018-09-27

Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT03486873Solid Tumors, Hematologic Malignancies

DrugsPembrolizumab/Favezelimab·) Berahyaluronidase alfa·Olaparib·Lenvatinib

Merck Sharp & Dohme LLC

Phase 3

3,500

Üsküdar /Istanbul, Balçova, Adana, Ankara, Antalya, Edirne, Erzurum, Istanbul

2018-08-21

Active, closed

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

NCT03519945Ulcerative Colitis

DrugMirikizumab

Eli Lilly and Company

Phase 3

1,058

Antalya, Bornova, Kocaeli, Mersin

2018-07-18

Active, closed

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

NCT03178552Non-Small Cell Lung Cancer

DrugsCobimetinib·Divarasib·Vemurafenib·Entrectinib

Hoffmann-La Roche

Phase 2/3

1,000

Adana, Antalya, Edirne, Istanbul, Kar??yaka, Sihhiye/Ankara

2017-09-22

Active, closed

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer

NCT03155997Breast Cancer

DrugAbemaciclib

Eli Lilly and Company

Phase 3

5,637

Istanbul- Fatih, Üsküdar/stanbul, Bornova, Izmir, Karsiyaka, Ankara, Adana, Antalya, Edirne

2017-07-12

Active, closed

A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

NCT02711553Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer

DrugsRamucirumab·Gemcitabine·Cisplatin

Eli Lilly and Company

Phase 2

309

Adana, Ankara, Antalya, Edirne, Istanbul

2016-05-19

Active, closed

A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

NCT02152631Non Small Cell Lung Cancer

DrugsErlotinib·Abemaciclib

Eli Lilly and Company

Phase 3

453

Ankara, Antalya, Edirne, Istanbul, Izmir

2014-10-03

Recruiting

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

NCT01949129Acute Lymphoblastic Leukaemia

DrugsGrafalon·Treosulfan·Thiotepa·Busulfan

St. Anna Kinderkrebsforschung

Phase 2/3

1,800

Ankara, Antalya, Istanbul, Izmir, Kayseri

2013-04

Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-turkey/city/antalya

Query this register directly

GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,443 studies in total at the last sync on 10 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 267 of those studies with a site in Antalya.

How many clinical trials are recruiting in Antalya?

119 of the 267 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:18 UTC sync. A further 37 have not yet opened recruitment, 108 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Antalya), 267 studies
Phase	Studies	Recruiting	Share
Phase 3	138	63	51.7%
Not applicable	49	16	18.4%
Observational	47	24	17.6%
Phase 2	16	5	6%
Phase 2/3	11	8	4.1%
Phase 4	3	0	1.1%
Phase 1/2	2	2	0.7%
Phase 1	1	1	0.4%

Most active sponsors

Lead sponsors with the most studies (Antalya)
Lead sponsor	Studies	Recruiting
AstraZeneca	31	20
Akdeniz University	28	7
Eli Lilly and Company	21	8
Janssen Research & Development, LLC	16	9
Antalya Training and Research Hospital	13	8
Merck Sharp & Dohme LLC	13	5
Antalya Health Sciences University	10	4
Hoffmann-La Roche	9	2
Antalya City Hospital	7	2
AbbVie	6	0

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.